The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Thu, May 19, 2022 | 17:21
Health & Science
Concerns on mix-and-match vaccinations rise after first death reported in Korea
Posted : 2021-07-23 16:24
Updated : 2021-07-25 18:15
Print Preview
Font Size Up
Font Size Down
People are observed for possible side effects after receiving their COVID-19 vaccine injections at a vaccination center in Seodaemun District, Seoul, Thursday. Yonhap
People are observed for possible side effects after receiving their COVID-19 vaccine injections at a vaccination center in Seodaemun District, Seoul, Thursday. Yonhap

By Lee Hyo-jin

Concerns are rising over mix-and-match inoculation of COVID-19 vaccines, following the death of a police officer who received a Pfizer dose for his second shot after an AstraZeneca for his first one.

This is the first death reported since July 5 when the Korean government introduced mix-and-match inoculations, using the AstraZeneca vaccine for the first dose and Pfizer for the second.

A 52-year-old police officer at Chilgok police station in North Gyeongsang Province died, July 20, three days after having been administered with a Pfizer dose. After his family found him unconscious at home around 2 a.m., he was transferred to a nearby hospital, but was pronounced dead about an hour later.

He received his first shot of the AstraZeneca dose April 28, followed by a Pfizer vaccine on July 17. He exhibited symptoms of headache and chills after the second dose, according to his family.

The Korea Disease Control and Prevention Agency (KDCA) said it will take the incident seriously and launch a thorough investigation looking for any correlation between his death and the vaccination.

"We will announce the final results after reviewing the results of the ongoing epidemiological investigation and autopsy findings," Bae Kyung-taek, a senior KDCA official, said at a briefing, Thursday.

Around 820,000 people here have received mixed vaccines, among some 6.7 million fully vaccinated individuals as of Thursday, according to the KDCA.

"As this is the first death reported after a cross-vaccination, it is very important for health authorities to relieve public anxiety by announcing accurate investigation results," said Chon Eun-mi, a professor of respiratory medicine at Ewha Womans University Mokdong Hospital.

"The government should also consider giving people more choice on mix-and-match vaccinations."

People are observed for possible side effects after receiving their COVID-19 vaccine injections at a vaccination center in Seodaemun District, Seoul, Thursday. Yonhap
Vials with Pfizer-BioNTech and AstraZeneca coronavirus vaccine labels are seen in this March 19 photo. Reuters-Yonhap

Kim Woo-joo, a professor of infectious medicine at Korea University also said, "It would have been better if eligible recipients for mix-and match vaccines were given a choice like in Germany."

Although emerging studies from overseas indicate that interchanging the vaccines may lead to stronger immune response, some countries are against the protocol citing a lack of data on safety and efficacy.

Data has been released from trials in Spain and the United Kingdom, which suggest that mixing AstraZeneca and Pfizer vaccines triggers an immune response similar, or even stronger than two doses of the same vaccine. A recent study in Germany revealed similar results that the immune response of mixing coronavirus doses was better than two AstraZeneca shots.

Based on such findings, several governments are interchanging the vaccines amid ongoing global shortage in vaccine supply.

Canada has decided to offer mRNA vaccines ― Moderna or Pfizer ― as a second shot to people who have received a first dose of the adenovirus AstraZeneca vaccine. The Thai government also adopted the policy by mixing Sinovac vaccine for a first shot with AstraZeneca for a second one.

Meanwhile, the U.S. has decided against mixing the vaccines, with the CDC firmly stating that "COVID-19 vaccines are not interchangeable," and thus "Both doses of the series should be completed with the same product."


Emaillhj@koreatimes.co.kr Article ListMore articles by this reporter
 
  • People in North Korea trapped in famine and pandemic [PHOTOS]
  • Kim says Chinese permanent residents should be stripped of right to vote in Korea
  • Anti-LGBTQ sentiment widespread in Korea: survey
  • South Korea to join US-led Indo-Pacific economic initiative
  • Protecting Korea's semiconductor leadership
  • CJ, Ottogi uneasy about Harim's tactics to sell new cooked rice
  • [INTERVIEW] Yoon's efforts to bolster Korea-US alliance will inevitably disturb China
  • North Korea asks China, Russia for help amid COVID crisis: reports
  • Luna debacle casts ripple effect over Korean stocks
  • Fear of deadliest famine in 1990s haunts North Korea amid national lockdown
  • Le Sserafim member Kim Ga-ram's bullying allegations resurface Le Sserafim member Kim Ga-ram's bullying allegations resurface
  • PSY's first boy group TNX makes much-anticipated debut with EP 'Way Up' PSY's first boy group TNX makes much-anticipated debut with EP 'Way Up'
  • Girls' Generation to make comeback in August after five years Girls' Generation to make comeback in August after five years
  • Musical 'Beethoven' to hit stage next year Musical 'Beethoven' to hit stage next year
  • 'Doctor Strange 2' tops 5 million admissions 'Doctor Strange 2' tops 5 million admissions
DARKROOM
  • People in North Korea trapped in famine and pandemic [PHOTOS]

    People in North Korea trapped in famine and pandemic [PHOTOS]

  • 2022 Pulitzer Prize: Bearing witness to history

    2022 Pulitzer Prize: Bearing witness to history

  • Worsening drought puts millions at risk

    Worsening drought puts millions at risk

  • Our children deserve the best

    Our children deserve the best

  • End of mask mandates

    End of mask mandates

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group